Calcium folinate pentahydrate
Chemotherapy Effect
Sun Yat-sen UniversitySmall moleculePhase 3Active
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 57/ 100
- Competitive Position
- 81/ 100
Competitive context
31 Active assets in the Chemotherapy Effect cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Docetaxel The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 4 | BB |
Idarubicine Fujian Medical University Union Hospital | Phase 4 | BB |
Eloxatin Linhui Peng | Phase 3 | BB |
Vinorelbine Zhiyong Yu | Phase 3 | B |
FLUOROURACILUM Linhui Peng | Phase 3 | B |
View all 50 →
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →